136 related articles for article (PubMed ID: 38040009)
1. Evaluating the epidemiology of clozapine-associated neutropenia among people on clozapine across Australia and Aotearoa New Zealand: a retrospective cohort study.
Northwood K; Myles N; Clark SR; Every-Palmer S; Myles H; Kisely S; Warren N; Siskind D
Lancet Psychiatry; 2024 Jan; 11(1):27-35. PubMed ID: 38040009
[TBL] [Abstract][Full Text] [Related]
2. Maximizing clozapine utilization while minimizing blood dyscrasias: evaluation of patient demographics and severity of events.
Demler TL; Morabito NE; Meyer CE; Opler L
Int Clin Psychopharmacol; 2016 Mar; 31(2):76-83. PubMed ID: 26565383
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis examining the epidemiology of clozapine-associated neutropenia.
Myles N; Myles H; Xia S; Large M; Kisely S; Galletly C; Bird R; Siskind D
Acta Psychiatr Scand; 2018 Aug; 138(2):101-109. PubMed ID: 29786829
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
[TBL] [Abstract][Full Text] [Related]
6. Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014.
Hollingworth SA; Winckel K; Saiepour N; Wheeler AJ; Myles N; Siskind D
Psychopharmacology (Berl); 2018 Jul; 235(7):1915-1921. PubMed ID: 29589067
[TBL] [Abstract][Full Text] [Related]
7. Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitals.
Oloyede E; Dzahini O; Barnes N; Mijovic A; Gandhi S; Stuart-Smith S; de Witte T; Taylor D; Whiskey E
BMC Psychiatry; 2021 Oct; 21(1):502. PubMed ID: 34645395
[TBL] [Abstract][Full Text] [Related]
8. Risk of neutropenia among clozapine users and non-users: results from 5,847 patients.
Goldani AAS; Rabelo-da-Ponte FD; Feiten JG; Lobato MIR; Belmonte-de-Abreu PS; Gama CS
Braz J Psychiatry; 2022; 44(1):21-25. PubMed ID: 34730717
[TBL] [Abstract][Full Text] [Related]
9. Clozapine treatment in Australia: a review of haematological monitoring.
Copolov DL; Bell WR; Benson WJ; Keks NA; Strazzeri DC; Johnson GF
Med J Aust; 1998 May; 168(10):495-7. PubMed ID: 9631674
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study.
Oloyede E; Dzahini O; Abolou Z; Gee S; Whiskey E; Malhotra D; Hussain M; Osborne I; Casetta C; McGuire P; MacCabe JH; Taylor D
Br J Psychiatry; 2023 Aug; 223(2):382-388. PubMed ID: 37092691
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for neutropenia in clozapine-treated children and adolescents with childhood-onset schizophrenia.
Maher KN; Tan M; Tossell JW; Weisinger B; Gochman P; Miller R; Greenstein D; Overman GP; Rapoport JL; Gogtay N
J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):110-6. PubMed ID: 23510445
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 infection causes a reduction in neutrophil counts in patients taking clozapine.
Gee S; Taylor D
J Psychiatry Neurosci; 2021 Mar; 46(2):E232-E237. PubMed ID: 33703870
[TBL] [Abstract][Full Text] [Related]
13. Blood dyscrasias in clozapine-treated patients in Italy.
Lambertenghi Deliliers G
Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Safety of Clozapine Use in Patients With Benign Neutropenia.
Richardson CM; Davis EA; Vyas GR; DiPaula BA; McMahon RP; Kelly DL
J Clin Psychiatry; 2016 Nov; 77(11):e1454-e1459. PubMed ID: 27736047
[TBL] [Abstract][Full Text] [Related]
15. Hematological adverse events in clozapine-treated children and adolescents.
Gerbino-Rosen G; Roofeh D; Tompkins DA; Feryo D; Nusser L; Kranzler H; Napolitano B; Frederickson A; Henderson I; Rhinewine J; Kumra S
J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):1024-31. PubMed ID: 16175107
[TBL] [Abstract][Full Text] [Related]
16. Clozapine-Induced Gastrointestinal Hypomotility: A 22-Year Bi-National Pharmacovigilance Study of Serious or Fatal 'Slow Gut' Reactions, and Comparison with International Drug Safety Advice.
Every-Palmer S; Ellis PM
CNS Drugs; 2017 Aug; 31(8):699-709. PubMed ID: 28623627
[TBL] [Abstract][Full Text] [Related]
17. Experience of maintaining clozapine medication in patients with 'red-alert zone' neutropenia: long-term follow-up results.
Ahn YM; Jeong SH; Jang HS; Koo YJ; Kang UG; Lee KY; Kim YS
Int Clin Psychopharmacol; 2004 Mar; 19(2):97-101. PubMed ID: 15076018
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the Effect of the Changes in FDA Guidelines for Clozapine Monitoring.
Sultan RS; Olfson M; Correll CU; Duncan EJ
J Clin Psychiatry; 2017; 78(8):e933-e939. PubMed ID: 28742291
[TBL] [Abstract][Full Text] [Related]
19. Continuation of Treatment With Clozapine After an Episode of Neutropenia.
Tirupati S; Gordon T
J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):320-322. PubMed ID: 33657071
[TBL] [Abstract][Full Text] [Related]
20. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J
Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
